IRIS
STAROPOLI, Nicoletta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 781
AS - Asia 650
EU - Europa 456
SA - Sud America 203
AF - Africa 19
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.112
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 744
SG - Singapore 258
IT - Italia 255
BR - Brasile 155
CN - Cina 129
VN - Vietnam 93
DE - Germania 73
IN - India 52
BD - Bangladesh 35
HK - Hong Kong 35
GB - Regno Unito 29
CA - Canada 21
FI - Finlandia 20
AR - Argentina 17
NL - Olanda 14
SE - Svezia 14
RU - Federazione Russa 13
ID - Indonesia 10
MX - Messico 10
TR - Turchia 9
EC - Ecuador 8
CL - Cile 7
ES - Italia 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
FR - Francia 6
ZA - Sudafrica 6
CO - Colombia 5
IQ - Iraq 4
JP - Giappone 4
PK - Pakistan 4
AT - Austria 3
CR - Costa Rica 3
KE - Kenya 3
MA - Marocco 3
PL - Polonia 3
PY - Paraguay 3
EG - Egitto 2
JO - Giordania 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UA - Ucraina 2
UZ - Uzbekistan 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BJ - Benin 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
IL - Israele 1
KG - Kirghizistan 1
KI - Kiribati 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
Totale 2.112
Salva come PNG Salva come JPEG
Città #
San Jose 151
Singapore 102
Ashburn 92
Dallas 73
Munich 59
Chandler 46
Ho Chi Minh City 41
Bengaluru 36
Hefei 36
Santa Clara 36
Hong Kong 35
Milan 27
Chicago 25
Beijing 24
London 21
New York 21
Turku 19
Hanoi 18
Catanzaro 17
Los Angeles 15
São Paulo 15
Naples 13
Rome 13
Carbonia 12
Lawrence 11
Princeton 11
The Dalles 11
Wilmington 9
Boardman 7
Ottawa 7
Parma 7
Amsterdam 6
Council Bluffs 6
Guangzhou 6
Haiphong 6
Montreal 6
Bologna 5
Charlotte 5
Orem 5
Brasília 4
Buffalo 4
Chennai 4
Da Nang 4
Ercolano 4
Melito di Porto Salvo 4
Messina 4
Olomouc 4
Porto Alegre 4
Reggio Calabria 4
Santiago 4
Shanghai 4
Tokyo 4
Afragola 3
Ankara 3
Atlanta 3
Belo Horizonte 3
Biên Hòa 3
Campina Grande 3
Carapicuíba 3
Catania 3
Curitiba 3
Guayaquil 3
Houston 3
Manaus 3
Moscow 3
Nairobi 3
Nuremberg 3
Redmond 3
Rio de Janeiro 3
Santo Stefano di Rogliano 3
Warsaw 3
Albignasego 2
Amman 2
Augusta 2
Barquisimeto 2
Benevento 2
Bisignano 2
Bismarck 2
Boston 2
Brooklyn 2
Campinas 2
Canoas 2
Cavallino 2
Columbus 2
Des Moines 2
Dhaka 2
Esslingen am Neckar 2
Florence 2
Florianópolis 2
Gatchina 2
Guarulhos 2
Jiaxing 2
Johannesburg 2
Lahore 2
Madrid 2
Manchester 2
Marcianise 2
Medellín 2
Mexico City 2
Mountain View 2
Totale 1.222
Salva come PNG Salva come JPEG
Nome #
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 117
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 100
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer 88
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 87
Pembrolizumab-Induced Psoriasis in Metastatic Melanoma: Activity and Safety of Apremilast, a Case Report 82
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab 82
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 78
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 76
Cardiotoxicity of anti-HER2 drugs in the treatment of metastatic breast cancer: Case report 76
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 75
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. (CO-FIRST AUTHOR) 75
Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients 73
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 71
Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients 69
Prevalence of Non-Erosive Esophageal Phenotypes in children: a European multicenter study 67
Polymorphic variants in NR1I3 and UGT2B7 predict taxane neurotoxicity and have prognostic relevance in breast cancer patients: a case-control study. 65
Modeling UGT2B7 and NR1I3 genes through multilayer network to highlight hidden link with taxane neurotoxicity 59
Real-World Clinical Outcomes of Ribociclib in Combination with a Non-Steroidal Aromatase Inhibitor and a Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal HR+/HER2− Advanced Breast Cancer Patients: An Italian Managed Access Program 58
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis 56
Economic Evaluation Of A New Non-Antibiotic First-line Treatment Of Recurrent Urinary Tract Infections 54
Personalized medicine in colorectal cancer diagnosis and treatment: a systematic review of health economic evaluations 54
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up 54
Gut Microbiota Are a Novel Source of Biomarkers for Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC) 53
Bioinformatic challenges for pharmacogenomic study: tools for genomic data analysis 53
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 53
Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity 48
UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma 45
Ramucirumab In Gastric Cancer Treatment: An Economic Evaluation 45
LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation 45
Frontline therapy CLL without 17p del/p53 aberrations: systematic review and Bayesian network meta-analysis 42
Network meta-analysis of randomized trials in multiple myeloma: efficacy and safety in relapsed/refractory patients. 37
First-line systemic treatment for hepatocellular carcinoma: A systematic review and network meta-analysis 36
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis 32
Why Do You Treat pCR Patient With Pertuzumab and Trastuzumab? 31
Risk-Based Therapeutic Strategies for HER2-Positive Early Breast Cancer: A Consensus Paper 30
Totale 2.166
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.069
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202245 0 0 1 17 0 2 0 9 4 8 2 2
2022/2023176 24 9 5 8 14 15 4 7 26 28 31 5
2023/2024139 44 10 12 6 7 26 1 1 0 7 13 12
2024/2025495 32 13 11 8 20 78 15 20 42 8 104 144
2025/20261.275 74 114 153 188 123 60 130 93 121 91 91 37
Totale 2.166